[go: up one dir, main page]

MX2019010832A - Tratamiento para la gingivitis. - Google Patents

Tratamiento para la gingivitis.

Info

Publication number
MX2019010832A
MX2019010832A MX2019010832A MX2019010832A MX2019010832A MX 2019010832 A MX2019010832 A MX 2019010832A MX 2019010832 A MX2019010832 A MX 2019010832A MX 2019010832 A MX2019010832 A MX 2019010832A MX 2019010832 A MX2019010832 A MX 2019010832A
Authority
MX
Mexico
Prior art keywords
individual
oral
gingivitis
mouth
bacteria
Prior art date
Application number
MX2019010832A
Other languages
English (en)
Other versions
MX393086B (es
Inventor
Charles Reynolds Eric
Original Assignee
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2017900893A external-priority patent/AU2017900893A0/en
Application filed by Univ Melbourne filed Critical Univ Melbourne
Publication of MX2019010832A publication Critical patent/MX2019010832A/es
Publication of MX393086B publication Critical patent/MX393086B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00—Preparations for dentistry
    • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/838—Phosphorus compounds, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58—Metal complex; Coordination compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se refiere a composiciones y su uso para el cuidado bucal. En particular, las composiciones y metodos son para mantener la salud bucal y/o tratar diversas afecciones bucales tales como la gingivitis. La presente invencion se refiere a metodos y usos de fosfato de calcio amorfo estabilizado (ACP) y/o fosfato de fluoruro de calcio amorfo estabilizado (ACFP) en la preparacion de un medicamento para reducir las bacterias bucales patógenas en un sitio bucal en un individuo; aumentar las bacterias bucales comensales en un sitio bucal en un individuo; disminuir la proporción de bacterias bucales patógenas en un sitio bucal en un individuo; inhibir la disbiosis bucal; reducir la inflamación gingival en un individuo que lo necesita; tratar la gingivitis en un individuo que lo necesita; y tratar la gingivitis crónica en un individuo que lo necesita.
MX2019010832A 2017-03-14 2018-03-14 Tratamiento para la gingivitis. MX393086B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2017900893A AU2017900893A0 (en) 2017-03-14 Treatment for gingivitis
PCT/AU2018/050231 WO2018165708A1 (en) 2017-03-14 2018-03-14 Treatment for gingivitis

Publications (2)

Publication Number Publication Date
MX2019010832A true MX2019010832A (es) 2019-10-30
MX393086B MX393086B (es) 2025-03-24

Family

ID=63521651

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019010832A MX393086B (es) 2017-03-14 2018-03-14 Tratamiento para la gingivitis.

Country Status (15)

Country Link
US (2) US11717536B2 (es)
EP (2) EP3595615B1 (es)
JP (1) JP7142943B2 (es)
KR (2) KR102862249B1 (es)
CN (1) CN110475533A (es)
AU (2) AU2018233577B2 (es)
CA (1) CA3055091A1 (es)
EA (1) EA201991933A1 (es)
ES (1) ES2975419T3 (es)
MX (1) MX393086B (es)
MY (1) MY197428A (es)
PH (1) PH12019550157A1 (es)
PL (1) PL3595615T3 (es)
SG (2) SG10202110136XA (es)
WO (1) WO2018165708A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2705826T3 (pl) 2006-02-09 2020-11-02 The University Of Melbourne Kompozycja fluorku i sposoby mineralizacji zębów
KR102221531B1 (ko) 2013-07-23 2021-03-02 더 유니버시티 오브 멜버른 치아 광화를 위한 조성물 및 방법
RU2716134C2 (ru) 2013-12-24 2020-03-06 Де Юниверсити Оф Мельбурн Стабилизированные композиции на основе олова (II)
SG11201907950VA (en) * 2017-03-14 2019-09-27 Univ Melbourne Complexes for treating sensitivity
EP3595615B1 (en) 2017-03-14 2024-01-10 The University Of Melbourne Treatment for gingivitis
WO2025097213A1 (en) * 2023-11-09 2025-05-15 The University Of Melbourne Compositions and methods for treating halitosis

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5112A (en) 1847-05-15 Cast-iron car-wheel
US122A (en) 1837-02-10 Improvement in the machine for weighing heavy bodies
US5968A (en) 1848-12-12 Parlor-stove
US746A (en) 1838-05-25 Improvement in the process of coloring hats, furs
US758A (en) 1838-05-30 Mode op
US3864471A (en) 1968-12-20 1975-02-04 Colgate Palmolive Co Stable dentifrices containing a monofluorophosphate, an insoluble metaphosphate, and calcium carbonate
US3966901A (en) 1970-12-29 1976-06-29 Colgate-Palmolive Company Dentifrice preparation
US4080440A (en) 1974-12-13 1978-03-21 The Procter & Gamble Company Method for remineralizing tooth enamel
US4157386A (en) 1978-05-18 1979-06-05 Rochelle Paul J Soft, chewable lozenge forming a sticky coating on teeth when combined with saliva in the mouth which is removable only by brushing
US4588763A (en) 1978-06-01 1986-05-13 Braennstroem Martin Ethyl acetate as solvent in cavity liners
NZ199891A (en) 1981-03-04 1985-07-31 Univ Melbourne Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US4357318A (en) 1981-07-31 1982-11-02 Richardson-Vicks Inc. Dentifrices with improved soluble fluoride availability
US4522805A (en) 1983-06-08 1985-06-11 Norman Gordon Tooth and gum dentifrice
US4672032A (en) 1983-11-09 1987-06-09 University Of Southern California Dental enamel production
CA1315480C (en) 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
US5015628A (en) 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
US6056930A (en) 1989-05-24 2000-05-02 American Dental Association Health Foundation Methods and compositions for mineralizing and fluoridating calcified tissues
US5227154A (en) 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus
ES2144458T3 (es) 1992-06-29 2000-06-16 Univ Melbourne Tratamiento para dientes sensibles.
CH684773A5 (fr) 1992-12-28 1994-12-30 Nestle Sa Composition alimentaire anti-cariogène.
JP3471431B2 (ja) 1994-07-18 2003-12-02 株式会社ジーシー 歯科用グラスアイオノマーセメント組成物
JP3340265B2 (ja) 1994-11-21 2002-11-05 一枝 山岸 歯の漂白剤
KR0140248B1 (ko) 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
ATE206877T1 (de) 1995-06-16 2001-11-15 Nestle Sa Fluorierte kasein-mizellen
US6036944A (en) 1995-08-08 2000-03-14 Enamelon, Inc. Processes for the remineralization and mineralization of teeth
JP2974604B2 (ja) 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JP4040705B2 (ja) 1996-01-24 2008-01-30 株式会社サンギ 口腔組成物
AUPN898296A0 (en) 1996-03-28 1996-04-26 Nulite Systems International Pty Ltd Elastomeric state glass ionomer cement
US5741773A (en) 1996-04-26 1998-04-21 Colgate Palmolive Company Storage stable dentifrice composition containing an antibacterial casein glycomacropeptide adjuvant
JP2975337B2 (ja) 1997-02-20 1999-11-10 雪印乳業株式会社 カルシウム複合体
US5986065A (en) 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
AUPO566297A0 (en) * 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
JPH11228327A (ja) 1998-02-18 1999-08-24 Gc Corp 歯科用ペースト系グラスアイオノマーセメント組成物
JP3742523B2 (ja) 1998-02-27 2006-02-08 雪印乳業株式会社 高分子型カルシウム・ホスホペプチド複合体
US6120754A (en) 1998-03-11 2000-09-19 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Remineralization of teeth
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
JP4267830B2 (ja) 1999-03-25 2009-05-27 キャドバリー・アダムズ・ユーエスエイ・エルエルシー 口内保護チューインガムおよび糖菓
US6846500B1 (en) 1999-03-25 2005-01-25 Cadbury Adams Usa Llc Oral care chewing gums and method of use
FR2791573B1 (fr) 1999-03-30 2003-04-11 Pf Medicament Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
US6149894A (en) 1999-05-14 2000-11-21 Colgate Palmolive Company Method for the manufacture of toothpaste
US6521215B2 (en) 1999-05-28 2003-02-18 Devin Okay Compositions and methods for tooth treatment
US6685920B2 (en) 1999-11-12 2004-02-03 The Procter & Gamble Company Method of protecting teeth against erosion
JP2001144695A (ja) 1999-11-17 2001-05-25 Matsushita Electric Ind Co Ltd 音声処理装置及び音声処理方法
GB9929919D0 (en) 1999-12-17 2000-02-09 Hannah Research Inst The Calcium phosphate nanoclusters and their applications
WO2002071985A1 (en) 2001-03-14 2002-09-19 Drexel University Polymeric bioresorbable composites containing an amorphous calcium phosphate polymer ceramic for bone repair and replacement
AUPR517701A0 (en) 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
WO2003059304A1 (en) * 2002-01-03 2003-07-24 The Procter & Gamble Company Stable oral compositions comprising casein phosphopeptide complexes and flouride
MXPA04006541A (es) 2002-01-03 2004-10-04 Procter & Gamble Composiciones bucales estables que contienen complejos de fosfopeptido de caseina y fluoruro.
NZ522071A (en) 2002-10-18 2005-07-29 Patrick Joseph Silcock Hydrolysed casein phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation
US8591867B2 (en) 2002-12-27 2013-11-26 Kao Corporation Oral preparation system
JP3853785B2 (ja) 2002-12-27 2006-12-06 花王株式会社 口腔用組成物
JP4340069B2 (ja) 2003-01-10 2009-10-07 雪印乳業株式会社 カルシウム複合体の製造法
US20050089481A1 (en) 2003-10-23 2005-04-28 Gc Corporation Composition for caries prevention
JP2005145952A (ja) 2003-10-23 2005-06-09 Gc Corp う蝕予防用組成物
US20050118115A1 (en) 2003-10-24 2005-06-02 Fontenot Mark G. Accelerated tooth whitening method, composition and kit
US20060183081A1 (en) 2004-09-27 2006-08-17 Al Bevilacqua Tooth bleaching system and method
NZ555335A (en) 2004-11-25 2010-10-29 Univ Melbourne Phosphopeptide stabilised amorphous calcium phosphate complexes produced under acidic conditions
US7380375B2 (en) 2004-12-14 2008-06-03 Rite-Hite Holding Corporation Alarm system for a loading dock
CN104013963A (zh) 2005-06-07 2014-09-03 墨尔本大学 牙齿矿化
CA2612172C (en) 2005-06-24 2013-05-14 The University Of Melbourne Ionic complexes
EA011125B1 (ru) 2005-11-25 2008-12-30 Общество С Ограниченной Ответственностью "Вдс" Лечебно-профилактический состав для ухода за полостью рта
US20070254260A1 (en) 2005-12-02 2007-11-01 Alden Wayne S Iv Oral care compositions, methods, devices and systems
PL2705826T3 (pl) 2006-02-09 2020-11-02 The University Of Melbourne Kompozycja fluorku i sposoby mineralizacji zębów
WO2008089066A1 (en) 2007-01-12 2008-07-24 Mcneil-Ppc, Inc. Mineralization toothpaste
MX2010005542A (es) 2008-02-08 2010-06-22 Colgate Palmolive Co Producto para el cuidado oral y metodos de uso y fabricacion del mismo.
GB0807224D0 (en) 2008-04-21 2008-05-28 Univ Dundee Remineralisation of calcified tissue
US9849310B2 (en) 2008-06-24 2017-12-26 Dental Alliance Holdings, Llc Dental appliance, oral care product and method of preventing dental disease
US9226895B2 (en) 2008-07-30 2016-01-05 Ultradent Products, Inc. Methods and kits for cleaning and remineralizing teeth
JP2010047494A (ja) 2008-08-20 2010-03-04 Gc Corp 歯牙塗布用組成物
JP5437692B2 (ja) * 2009-04-30 2014-03-12 インターコンチネンタル グレート ブランズ エルエルシー チューインガム組成物、チューインガム製品、及びこれらの製造方法
EP2432444B1 (en) 2009-05-18 2017-08-23 Colgate-Palmolive Company Oral compositions containing polyguanidinium compounds and methods of manufacture and use thereof
JP4693191B2 (ja) 2009-08-06 2011-06-01 日本歯科薬品株式会社 口腔用剤
JP2011073983A (ja) 2009-09-29 2011-04-14 Gc Corp 歯牙塗布用組成物
JP2011162470A (ja) 2010-02-09 2011-08-25 Gc Corp 歯牙用被覆材
JP6114036B2 (ja) 2010-02-12 2017-04-12 テオコープ ホールディング カンパニー，エルエルシー 歯の機械的抵抗力を改善する方法および組成物
US9539445B2 (en) 2010-11-22 2017-01-10 Taipei Medical University Type of anion-containing calcium phosphate compound for dental remineralization
EP3424516A1 (en) 2011-01-24 2019-01-09 Basf Se Oral health improving compositions
JP2013163656A (ja) 2012-02-10 2013-08-22 Gc Corp 歯磨剤
GB201202341D0 (en) 2012-02-10 2012-03-28 Periproducts Ltd Multicomponent oral care compostion
KR102221531B1 (ko) 2013-07-23 2021-03-02 더 유니버시티 오브 멜버른 치아 광화를 위한 조성물 및 방법
RU2716134C2 (ru) 2013-12-24 2020-03-06 Де Юниверсити Оф Мельбурн Стабилизированные композиции на основе олова (II)
CA2972105A1 (en) 2014-12-24 2016-06-30 The University Of Melbourne Mineralization fluoride compositions
SG11201907950VA (en) 2017-03-14 2019-09-27 Univ Melbourne Complexes for treating sensitivity
EP3595615B1 (en) 2017-03-14 2024-01-10 The University Of Melbourne Treatment for gingivitis
US20220183810A1 (en) 2019-03-13 2022-06-16 The University Of Melbourne Concealment of hypomineralised lesions
CA3133097A1 (en) 2019-03-13 2020-09-17 The University Of Melbourne Compositions and methods for promoting mineralization

Also Published As

Publication number Publication date
PH12019550157A1 (en) 2020-06-15
US20240016836A1 (en) 2024-01-18
ES2975419T3 (es) 2024-07-05
EP3595615A1 (en) 2020-01-22
KR102696078B1 (ko) 2024-08-16
AU2018233577A1 (en) 2019-09-26
BR112019018798A2 (pt) 2020-04-07
SG11201907951QA (en) 2019-09-27
MX393086B (es) 2025-03-24
EP4311576A2 (en) 2024-01-31
PL3595615T3 (pl) 2024-05-13
EP4311576A3 (en) 2024-04-10
JP2020514354A (ja) 2020-05-21
CA3055091A1 (en) 2018-09-20
WO2018165708A1 (en) 2018-09-20
AU2018233577B2 (en) 2021-08-19
NZ757005A (en) 2023-08-25
EA201991933A1 (ru) 2020-03-05
US11717536B2 (en) 2023-08-08
AU2021269317A1 (en) 2021-12-09
JP7142943B2 (ja) 2022-09-28
SG10202110136XA (en) 2021-10-28
EP3595615B1 (en) 2024-01-10
CN110475533A (zh) 2019-11-19
EP3595615A4 (en) 2020-12-02
MY197428A (en) 2023-06-16
US20200054672A1 (en) 2020-02-20
KR102862249B1 (ko) 2025-09-19
AU2021269317B2 (en) 2024-05-02
KR20190126141A (ko) 2019-11-08
KR20240055159A (ko) 2024-04-26

Similar Documents

Publication Publication Date Title
MX2019010832A (es) Tratamiento para la gingivitis.
CL2016000530A1 (es) Tratamiento de la osteoartritis y del dolor (divisional de sol. n°2298-13).
MX2022003072A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
MX2018003569A (es) Derivados de acido oleanolico modificado en c4 para la inhibicion de il-17 y otros usos.
BR112015001782A2 (pt) método para produzir uma composição para o tratamento de um dente lesionado
CL2017003066A1 (es) Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal
CO6710926A2 (es) Compuestos de n-heteroarilo
MX2017005108A (es) Formulaciones que contienen aceite de semilla de granada, aceite del fruto de rosa canina y oleorresina o extracto de inula viscosa.
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
MX379359B (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
MX2018004220A (es) Tetrahidropiranilsulfonas sustituidas con pirazolilo.
EA201591507A1 (ru) Лечение рассеянного склероза лахинимодом
MX379201B (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
CY1116234T1 (el) Υποκατεστημενα 2-οξυ-κινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
AR096854A1 (es) Composición farmacéutica para una liberación sostenida de lanreotide
CO2017004806A2 (es) Kit de partes para la preparación de composiciones de factor de crecimiento derivado de plaquetas recombinantes para tratar heridas
BR112017026834A2 (pt) composição compreendendo vitaminas b e vitaminas c e seu uso
BR112019006087A2 (pt) composição de cuidados bucais e método para beneficiar dentes de um indivíduo
TR201004464A2 (tr) Kemik erimesi için formülasyon.
CY1116158T1 (el) Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3
MX2024003249A (es) Formas solidas de 3-(5-fluorobenzofuran-3-il)-4-(5-metil-5h-[1,3]d ioxolo[4,5-f]indol-7-il)pirrol-2,5-diona.
MX2018004217A (es) Tetrahidropiranilsulfonas sustituidas con pirazolilo.
BR112016030728A2 (pt) método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença
ZA201906153B (en) Pharmaceutical compositions for combination therapy
IL250852B (en) Periodontal preparation